Raloxifene-mediated increase in matrix metalloproteinase-1 production by activated monocytes

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 8, 2001, Pages 1265-1268

  Ardans, Jeanette A ^a   Blum, Arnon ^b   Mangan, Paul R ^a   Wientroub, Shlomo ^c   Cannon III, Richard O ^b   Wahl, Larry M ^a,d  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Atherosclerosis; Matrix metalloproteinases; Monocytes; Plaque; Raloxifene

Indexed keywords

CYCLOOXYGENASE 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; RALOXIFENE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ACTIVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL;

EID: 0035573697     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0801.095083     Document Type: Article

References (15)

1. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle cell content
2. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques
3. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
4. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial: Multiple Outcomes of Raloxifene Evaluation
5. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
6. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management
7. 17β-Oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells
8. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms
9. Regulation of human monocyte matrix metalloproteinases by SPARC
10. Regulation of human peripheral blood monocyte collagenase by prostaglandins and anti-inflammatory drugs
11. Induction of macrophage metalloproteinases by extracellular matrix: Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms
12. Matrix metalloproteinases
13. Human monocyte-endothelial cell interaction induces synthesis of granulocyte-macrophage colony-stimulating factor
14. Raloxifene
15. 14C-labeled raloxifene in humans